Skip to main content

Table 3 Univariate Cox proportional hazard regression models of biochemical recurrence free survival (n = 15)

From: Toremifene, a selective estrogen receptor modulator, significantly improved biochemical recurrence in bone metastatic prostate cancer: a randomized controlled phase II a trial

 

Univariate

Variable

Hazard ratio

95 % index

p value

Age (≥74 vs. <74)

3.9

0.57–75

0.18

Serum PSA (ng/mL) (≥198 vs. <198)

1.9

0.33–15

0.45

J-CAPRA (≥9 vs. ≤8)

1.7

0.27–12

0.57

AR LI (≥93.5 vs. <93.5)

1.2

0.19–8.7

0.87

ERα LI (≥23.2 vs. <23.2)

0.40

0.05–2.5

0.32

ERβ LI (≥16.1 vs. <16.1)

0.73

0.09–4.4

0.73

TOPADT vs. MAB

1.1 e−9

0.64–0.64

0.023

RAPADT vs. MAB

0.5

0.069–3.2

0.48

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us